MAPT and Alzheimer disease: In late-stage disease (12-month-old Tau4RΔK-AP mice), we found that another novel microglia subtype emerged in response to tau pathology that we termed Late-stage AD-Associated Microglia (LADAM), which expresses MHC and S100 family genes.